Showing results (231-240 of 523) with videos related to
Sort By:
Pageof 53
Clinical Breast Cancer|May 19, 2007
Peripheral neurotoxicity of weekly paclitaxel chemotherapy: a schedule or a dose issue?Andrea Pace, Cecilia Nisticò, Federica Cuppone, et al.Biomedicines|February 27, 2026
PIK3CA Alterations in NSCLC: Clinical Characteristics of a "Neglected" Population of Oncogene-Addicted PatientsSabrina Rossi, Arianna Pagliaro, Silvia Masini, et al.World Journal of Gastroenterology|May 7, 2015
Metastatic pancreatic cancer: Is there a light at the end of the tunnel?Vanja Vaccaro, Isabella Sperduti, Sabrina Vari, et al.Journal of Bronchology & Interventional Pulmonology|July 1, 2024
Intrathoracic Lymph Node Microcalcifications are Associated With a High Prevalence of Malignancy and Anaplastic Lymphoma Kinase Rearrangement: The "Calce" StudyFausto Leoncini, Giovanni Sotgiu, Alessandra Cancellieri, et al.Clinical Lung Cancer|March 4, 2025
Supraclavicular Lymph Node Metastases in Advanced Lung Cancer: Prevalence and Analysis of Demographic, Clinical and Molecular CharacteristicsRocco Trisolini, Valeria Cetoretta, Giovanni Sotgiu, et al.Tumori|December 2, 2017
Thirty-day mortality and five-year survival in thoracic surgery: "real-world" assessment of outcomes from a single-institution auditAnna Cantarutti, Carlotta Galeone, Giovanni Leuzzi, et al.Expert Opinion on Investigational Drugs|June 13, 2015
An overview of angiogenesis inhibitors in Phase II studies for non-small-cell lung cancerSara Pilotto, Silvia Novello, Umberto Peretti, et al.Oncology|July 16, 2005
Weekly docetaxel in pretreated metastatic breast cancer patients: a phase I-II studyCecilia Nisticò, Francesco Cognetti, Luciano Frontini, et al.Critical Reviews in Oncology/Hematology|June 6, 2022
Effect of exercise on functional capacity in patients with advanced cancer: A meta-analysis of randomized controlled trialsAlice Avancini, Isabella Sperduti, Anita Borsati, et al.Internal and Emergency Medicine|December 18, 2020
Prognostic value of skeletal muscle mass during tyrosine kinase inhibitor (TKI) therapy in cancer patients: a systematic review and meta-analysisEmanuele Rinninella, Marco Cintoni, Pauline Raoul, et al.Pageof 53